LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 94

Search options

  1. Article ; Online: Repurposing of rabeprazole as an anti-

    García-Torres, Itzhel / De la Mora-De la Mora, Ignacio / López-Velázquez, Gabriel / Cabrera, Nallely / Flores-López, Luis Antonio / Becker, Ingeborg / Herrera-López, Juliana / Hernández, Roberto / Pérez-Montfort, Ruy / Enríquez-Flores, Sergio

    Journal of enzyme inhibition and medicinal chemistry

    2023  Volume 38, Issue 1, Page(s) 2231169

    Abstract: Trypanosoma ... ...

    Abstract Trypanosoma cruzi
    MeSH term(s) Humans ; Trypanosoma cruzi ; Triose-Phosphate Isomerase/chemistry ; Triose-Phosphate Isomerase/pharmacology ; Rabeprazole/pharmacology ; Rabeprazole/therapeutic use ; Drug Repositioning ; Chagas Disease/drug therapy ; Trypanocidal Agents/pharmacology
    Chemical Substances benzonidazole (YC42NRJ1ZD) ; Triose-Phosphate Isomerase (EC 5.3.1.1) ; Rabeprazole (32828355LL) ; Trypanocidal Agents
    Language English
    Publishing date 2023-07-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 2082578-X
    ISSN 1475-6374 ; 1475-6366
    ISSN (online) 1475-6374
    ISSN 1475-6366
    DOI 10.1080/14756366.2023.2231169
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Human Triosephosphate Isomerase Is a Potential Target in Cancer Due to Commonly Occurring Post-Translational Modifications.

    Enríquez-Flores, Sergio / De la Mora-De la Mora, Ignacio / García-Torres, Itzhel / Flores-López, Luis A / Martínez-Pérez, Yoalli / López-Velázquez, Gabriel

    Molecules (Basel, Switzerland)

    2023  Volume 28, Issue 16

    Abstract: Cancer involves a series of diseases where cellular growth is not controlled. Cancer is a leading cause of death worldwide, and the burden of cancer incidence and mortality is rapidly growing, mainly in developing countries. Many drugs are currently used, ...

    Abstract Cancer involves a series of diseases where cellular growth is not controlled. Cancer is a leading cause of death worldwide, and the burden of cancer incidence and mortality is rapidly growing, mainly in developing countries. Many drugs are currently used, from chemotherapeutic agents to immunotherapy, among others, along with organ transplantation. Treatments can cause severe side effects, including remission and progression of the disease with serious consequences. Increased glycolytic activity is characteristic of cancer cells. Triosephosphate isomerase is essential for net ATP production in the glycolytic pathway. Notably, some post-translational events have been described that occur in human triosephosphate isomerase in which functional and structural alterations are provoked. This is considered a window of opportunity, given the differences that may exist between cancer cells and their counterpart in normal cells concerning the glycolytic enzymes. Here, we provide elements that bring out the potential of triosephosphate isomerase, under post-translational modifications, to be considered an efficacious target for treating cancer.
    MeSH term(s) Humans ; Triose-Phosphate Isomerase/genetics ; Neoplasms/drug therapy ; Protein Processing, Post-Translational ; Cell Cycle ; Cell Proliferation
    Chemical Substances Triose-Phosphate Isomerase (EC 5.3.1.1)
    Language English
    Publishing date 2023-08-21
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 1413402-0
    ISSN 1420-3049 ; 1431-5165 ; 1420-3049
    ISSN (online) 1420-3049
    ISSN 1431-5165 ; 1420-3049
    DOI 10.3390/molecules28166163
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Testing New Peptides From

    Xicoténcatl-García, Lizbeth / Enriquez-Flores, Sergio / Correa, Dolores

    Frontiers in cellular and infection microbiology

    2019  Volume 9, Page(s) 368

    Abstract: Toxoplasma ... ...

    Abstract Toxoplasma gondii
    MeSH term(s) Adolescent ; Adult ; Amino Acid Sequence ; Antigens, Protozoan/immunology ; Computational Biology/methods ; Conserved Sequence ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Infant, Newborn ; Infectious Disease Transmission, Vertical ; Male ; Mexico/epidemiology ; Peptides/immunology ; Protein Conformation ; Protozoan Proteins/chemistry ; Protozoan Proteins/immunology ; Risk Assessment ; Serotyping/methods ; Structure-Activity Relationship ; Toxoplasma/classification ; Toxoplasma/immunology ; Toxoplasmosis/diagnosis ; Toxoplasmosis/epidemiology ; Toxoplasmosis/parasitology ; Toxoplasmosis/transmission ; Young Adult
    Chemical Substances Antigens, Protozoan ; Peptides ; Protozoan Proteins
    Language English
    Publishing date 2019-10-23
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2619676-1
    ISSN 2235-2988 ; 2235-2988
    ISSN (online) 2235-2988
    ISSN 2235-2988
    DOI 10.3389/fcimb.2019.00368
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The Giardial Arginine Deiminase Participates in

    Fernández-Lainez, Cynthia / de la Mora-de la Mora, Ignacio / Enríquez-Flores, Sergio / García-Torres, Itzhel / Flores-López, Luis A / Gutiérrez-Castrellón, Pedro / de Vos, Paul / López-Velázquez, Gabriel

    International journal of molecular sciences

    2022  Volume 23, Issue 19

    Abstract: Beyond the problem in public health that protist-generated diseases represent, understanding the variety of mechanisms used by these parasites to interact with the human immune system is of biological and medical relevance. ...

    Abstract Beyond the problem in public health that protist-generated diseases represent, understanding the variety of mechanisms used by these parasites to interact with the human immune system is of biological and medical relevance.
    MeSH term(s) Animals ; Giardia ; Giardiasis ; Humans ; Hydrolases ; Immunity ; Immunomodulation ; Molecular Docking Simulation ; Toll-Like Receptors
    Chemical Substances Toll-Like Receptors ; Hydrolases (EC 3.-) ; arginine deiminase (EC 3.5.3.6)
    Language English
    Publishing date 2022-09-30
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms231911552
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Improved yield, stability, and cleavage reaction of a novel tobacco etch virus protease mutant.

    Enríquez-Flores, Sergio / De la Mora-De la Mora, José Ignacio / Flores-López, Luis Antonio / Cabrera, Nallely / Fernández-Lainez, Cynthia / Hernández-Alcántara, Gloria / Guerrero-Beltrán, Carlos Enrique / López-Velázquez, Gabriel / García-Torres, Itzhel

    Applied microbiology and biotechnology

    2022  Volume 106, Issue 4, Page(s) 1475–1492

    Abstract: The protease catalytic subunit of the nuclear inclusion protein A from tobacco etch virus (TEVp) is widely used to remove tags and fusion proteins from recombinant proteins. Some intrinsic drawbacks to its recombinant production have been studied for ... ...

    Abstract The protease catalytic subunit of the nuclear inclusion protein A from tobacco etch virus (TEVp) is widely used to remove tags and fusion proteins from recombinant proteins. Some intrinsic drawbacks to its recombinant production have been studied for many years, such as low solubility, auto-proteolysis, and instability. Some point mutations have been incorporated in the amino acid protease sequence to improve its production. Here, a comprehensive review of each mutation reported so far has been made to incorporate them into a mutant called TEVp7M with a total of seven changes. This mutant with a His
    MeSH term(s) Chromatography, Affinity ; Endopeptidases/genetics ; Endopeptidases/metabolism ; Proteolysis ; Recombinant Fusion Proteins/metabolism
    Chemical Substances Recombinant Fusion Proteins ; Endopeptidases (EC 3.4.-) ; TEV protease (EC 3.4.-)
    Language English
    Publishing date 2022-01-29
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 392453-1
    ISSN 1432-0614 ; 0171-1741 ; 0175-7598
    ISSN (online) 1432-0614
    ISSN 0171-1741 ; 0175-7598
    DOI 10.1007/s00253-022-11786-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Improved yield, stability, and cleavage reaction of a novel tobacco etch virus protease mutant

    Enríquez-Flores, Sergio / De la Mora-De la Mora, José Ignacio / Flores-López, Luis Antonio / Cabrera, Nallely / Fernández-Lainez, Cynthia / Hernández-Alcántara, Gloria / Guerrero-Beltrán, Carlos Enrique / López-Velázquez, Gabriel / García-Torres, Itzhel

    Applied microbiology and biotechnology. 2022 Feb., v. 106, no. 4

    2022  

    Abstract: The protease catalytic subunit of the nuclear inclusion protein A from tobacco etch virus (TEVp) is widely used to remove tags and fusion proteins from recombinant proteins. Some intrinsic drawbacks to its recombinant production have been studied for ... ...

    Abstract The protease catalytic subunit of the nuclear inclusion protein A from tobacco etch virus (TEVp) is widely used to remove tags and fusion proteins from recombinant proteins. Some intrinsic drawbacks to its recombinant production have been studied for many years, such as low solubility, auto-proteolysis, and instability. Some point mutations have been incorporated in the amino acid protease sequence to improve its production. Here, a comprehensive review of each mutation reported so far has been made to incorporate them into a mutant called TEVp7M with a total of seven changes. This mutant with a His₇tag at N-terminus was produced with remarkable purification yields (55 mg/L of culture) from the soluble fraction in a single step affinity purification. The stability of His₇-TEVp7M was analyzed and compared with the single mutant TEVp S219V, making evident that His₇-TEVp7M shows very constant thermal stability against pH variation, whereas TEVp S219V is highly sensitive to this change. The cleavage reaction was optimized by determining the amount of protease that could cleave a 100-fold excess substrate in the shortest possible time at 30 °C. Under these conditions, His₇-TEVp7M was able to cleave His-tag in the buffers commonly used for affinity purification. Finally, a structural analysis of the mutations showed that four of them increased the polarity of the residues involved and, consequently, showed increased solubility of TEVp and fewer hydrophobic regions exposed to the solvent. Taken together, the seven changes studied in this work improved stability, solubility, and activity of TEVp producing enough protease to digest large amounts of tags or fusion proteins. KEY POINTS: • Production of excellent yields of a TEVp (TEVp7M) by incorporation of seven changes. • His-tag removal in an excess substrate in the common buffers used for purification. • Incorporated mutations improve polarity, stability, and activity of TEVp7M.
    Keywords Tobacco etch virus ; amino acids ; biotechnology ; hydrophobicity ; microbiology ; mutants ; pH ; protein subunits ; proteinases ; solubility ; solvents ; thermal stability
    Language English
    Dates of publication 2022-02
    Size p. 1475-1492.
    Publishing place Springer Berlin Heidelberg
    Document type Article
    ZDB-ID 392453-1
    ISSN 1432-0614 ; 0171-1741 ; 0175-7598
    ISSN (online) 1432-0614
    ISSN 0171-1741 ; 0175-7598
    DOI 10.1007/s00253-022-11786-5
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article: Differential effects on enzyme stability and kinetic parameters of mutants related to human triosephosphate isomerase deficiency.

    Cabrera, Nallely / Torres-Larios, Alfredo / García-Torres, Itzhel / Enríquez-Flores, Sergio / Perez-Montfort, Ruy

    Biochimica et biophysica acta. General subjects

    2018  Volume 1862, Issue 6, Page(s) 1401–1409

    Abstract: Human triosephosphate isomerase (TIM) deficiency is a very rare disease, but there are several mutations reported to be causing the illness. In this work, we produced nine recombinant human triosephosphate isomerases which have the mutations reported to ... ...

    Abstract Human triosephosphate isomerase (TIM) deficiency is a very rare disease, but there are several mutations reported to be causing the illness. In this work, we produced nine recombinant human triosephosphate isomerases which have the mutations reported to produce TIM deficiency. These enzymes were characterized biophysically and biochemically to determine their kinetic and stability parameters, and also to substitute TIM activity in supporting the growth of an Escherichia coli strain lacking the tim gene. Our results allowed us to rate the deleteriousness of the human TIM mutants based on the type and severity of the alterations observed, to classify four "unknown severity mutants" with altered residues in positions 62, 72, 122 and 154 and to explain in structural terms the mutation V231M, the most affected mutant from the kinetic point of view and the only homozygous mutation reported besides E104D.
    MeSH term(s) Anemia, Hemolytic, Congenital Nonspherocytic/enzymology ; Anemia, Hemolytic, Congenital Nonspherocytic/genetics ; Carbohydrate Metabolism, Inborn Errors/enzymology ; Carbohydrate Metabolism, Inborn Errors/genetics ; Enzyme Stability ; Humans ; Kinetics ; Models, Molecular ; Mutagenesis, Site-Directed ; Mutation ; Protein Conformation ; Triose-Phosphate Isomerase/chemistry ; Triose-Phosphate Isomerase/deficiency ; Triose-Phosphate Isomerase/genetics ; Triose-Phosphate Isomerase/metabolism
    Chemical Substances Triose-Phosphate Isomerase (EC 5.3.1.1)
    Language English
    Publishing date 2018-03-20
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 60-7
    ISSN 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2618 ; 1879-2650 ; 0304-4165 ; 0006-3002 ; 0005-2728 ; 0005-2736 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    ISSN (online) 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2618 ; 1879-2650
    ISSN 0304-4165 ; 0006-3002 ; 0005-2728 ; 0005-2736 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    DOI 10.1016/j.bbagen.2018.03.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Naturally occurring deamidated triosephosphate isomerase is a promising target for cell-selective therapy in cancer.

    Enríquez-Flores, Sergio / Flores-López, Luis A / De la Mora-De la Mora, Ignacio / García-Torres, Itzhel / Gracia-Mora, Isabel / Gutiérrez-Castrellón, Pedro / Fernández-Lainez, Cynthia / Martínez-Pérez, Yoalli / Olaya-Vargas, Alberto / de Vos, Paul / López-Velázquez, Gabriel

    Scientific reports

    2022  Volume 12, Issue 1, Page(s) 4028

    Abstract: Human triosephosphate isomerase (HsTIM) is a central glycolytic enzyme and is overexpressed in cancer cells with accelerated glycolysis. Triple-negative breast cancer is highly dependent on glycolysis and is typically treated with a combination of ... ...

    Abstract Human triosephosphate isomerase (HsTIM) is a central glycolytic enzyme and is overexpressed in cancer cells with accelerated glycolysis. Triple-negative breast cancer is highly dependent on glycolysis and is typically treated with a combination of surgery, radiation therapy, and chemotherapy. Deamidated HsTIM was recently proposed as a druggable target. Although thiol-reactive drugs affect cell growth in deamidated HsTIM-complemented cells, the role of this protein as a selective target has not been demonstrated. To delve into the usefulness of deamidated HsTIM as a selective target, we assessed its natural accumulation in breast cancer cells. We found that deamidated HsTIM accumulates in breast cancer cells but not in noncancerous cells. The cancer cells are selectively programmed to undergo cell death with thiol-reactive drugs that induced the production of methylglyoxal (MGO) and advanced glycation-end products (AGEs). In vivo, a thiol-reactive drug effectively inhibits the growth of xenograft tumors with an underlying mechanism involving deamidated HsTIM. Our findings demonstrate the usefulness of deamidated HsTIM as target to develop new therapeutic strategies for the treatment of cancers and other pathologies in which this post translationally modified protein accumulates.
    MeSH term(s) Breast Neoplasms ; Female ; Glycolysis ; Humans ; Proteins/metabolism ; Pyruvaldehyde/metabolism ; Sulfhydryl Compounds ; Triose-Phosphate Isomerase/metabolism
    Chemical Substances Proteins ; Sulfhydryl Compounds ; Pyruvaldehyde (722KLD7415) ; Triose-Phosphate Isomerase (EC 5.3.1.1)
    Language English
    Publishing date 2022-03-07
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-022-08051-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Further Evidence That Defects in Main Thyroid Dysgenesis-Related Genes Are an Uncommon Etiology for Primary Congenital Hypothyroidism in Mexican Patients: Report of Rare Variants in

    Alcántara-Ortigoza, Miguel Angel / Sánchez-Verdiguel, Iraís / Fernández-Hernández, Liliana / Enríquez-Flores, Sergio / González-Núñez, Aidy / Hernández-Martínez, Nancy Leticia / Sánchez, Carmen / González-Del Angel, Ariadna

    Children (Basel, Switzerland)

    2021  Volume 8, Issue 6

    Abstract: Mexico shows a high birth prevalence of congenital hypothyroidism (CH) due to thyroid dysgenesis (TD). ...

    Abstract Mexico shows a high birth prevalence of congenital hypothyroidism (CH) due to thyroid dysgenesis (TD).
    Language English
    Publishing date 2021-05-30
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2732685-8
    ISSN 2227-9067
    ISSN 2227-9067
    DOI 10.3390/children8060457
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Cloning, purification, and characterization of the 6-phosphogluconate dehydrogenase (6 PGDH) from Giardia lamblia.

    Morales-Luna, Laura / Hernández-Ochoa, Beatriz / Martínez-Rosas, Víctor / González-Valdez, Abigail / Cárdenas-Rodríguez, Noemi / Enríquez-Flores, Sergio / Marcial-Quino, Jaime / Gómez-Manzo, Saúl

    Molecular and biochemical parasitology

    2021  Volume 244, Page(s) 111383

    Abstract: Giardia lamblia, due to the habitat in which it develops, requires a continuous supply of intermediate compounds that allow it to survive in the host. The pentose phosphate pathway (PPP) provides essential molecules such as NADPH and ribulose-5-phosphate ...

    Abstract Giardia lamblia, due to the habitat in which it develops, requires a continuous supply of intermediate compounds that allow it to survive in the host. The pentose phosphate pathway (PPP) provides essential molecules such as NADPH and ribulose-5-phosphate during the oxidative phase of the pathway. One of the key enzymes during this stage is 6-phosphogluconate dehydrogenase (6 PGDH) for generating NADPH. Given the relevance of the enzyme, in the present work, the 6pgdh gene from G. lamblia was amplified and cloned to produce the recombinant protein (Gl-6 PGDH) and characterize it functionally and structurally after the purification of Gl-6 PGDH by affinity chromatography. The results of the characterization showed that the protein has a molecular mass of 54 kDa, with an optimal pH of 7.0 and a temperature of 36-42 °C. The kinetic parameters of Gl-6 PGDH were K
    MeSH term(s) Amino Acid Motifs ; Binding Sites ; Cloning, Molecular/methods ; Gene Expression ; Geobacillus stearothermophilus/chemistry ; Geobacillus stearothermophilus/enzymology ; Giardia lamblia/enzymology ; Giardia lamblia/genetics ; Gluconates/chemistry ; Gluconates/metabolism ; Humans ; Kinetics ; Models, Molecular ; NADP/chemistry ; NADP/metabolism ; Pentose Phosphate Pathway/genetics ; Phosphogluconate Dehydrogenase/chemistry ; Phosphogluconate Dehydrogenase/genetics ; Phosphogluconate Dehydrogenase/metabolism ; Protein Binding ; Protein Conformation, alpha-Helical ; Protein Conformation, beta-Strand ; Protein Interaction Domains and Motifs ; Protozoan Proteins/chemistry ; Protozoan Proteins/genetics ; Protozoan Proteins/metabolism ; Recombinant Proteins/chemistry ; Recombinant Proteins/genetics ; Recombinant Proteins/metabolism ; Ribulosephosphates/chemistry ; Ribulosephosphates/metabolism ; Structural Homology, Protein ; Substrate Specificity ; Thermodynamics
    Chemical Substances Gluconates ; Protozoan Proteins ; Recombinant Proteins ; Ribulosephosphates ; ribulose 5-phosphate (4151-19-3) ; NADP (53-59-8) ; Phosphogluconate Dehydrogenase (EC 1.1.1.43) ; 6-phosphogluconic acid (W31WK7B8U0)
    Language English
    Publishing date 2021-05-25
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 756166-0
    ISSN 1872-9428 ; 0166-6851
    ISSN (online) 1872-9428
    ISSN 0166-6851
    DOI 10.1016/j.molbiopara.2021.111383
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top